Skip to main content

Table 6 Mechanistic outcomes. Mean (SD) unless otherwise stated

From: The effect of targeted treatment on people with patellofemoral pain: a pragmatic, randomised controlled feasibility study

Outcome

Group

Baseline (SD)

Post Rx (SD)

Mean difference (baseline-post) (SD)

Confidence intervals (95%)

Mean difference (MT-UC) (95% CI)

ES (d) (MT - UC)

Hip abductor strength (Nm)

MT

91.02 (28.45)

99.40 (27.89)

8.39 (15.28)

−17.62, 0.85

−0.63 (−13.35, 12.09)

−0.04

UC

81.82 (31.76)

89.57 (33.43)

7.76 (14.59)

−17.56, 2.05

Knee extensor strength (Nm)

MT

91.44 (28.21)

93.12 (27.19)

1.677 (14.57)

−10.48, 7.12

7.96 (−2.88,18.79)

0.62

UC

94.32 (44.10)

103.95 (46.09)

9.64 (10.15)

−16.46, − 2.82

Peak Hip Adduction (°)

MT

5.74 (2.70)

5.92 (2.79)

−0.17 (2.84)

−1.89, 1.54

−0.14 (−3.12, 2.85)

0.04

UC

3.70 (3.68)

3.74 (4.99)

−0.04 (4.18)

−2.84, 2.77

Peak Hip Internal Rotation (°)

MT

−4.49 (3.26)

−5.95 (5.26)

1.45 (4.98)

−1.56, 4.46

1.70 (−2.56, 5.97)

−0.34

UC

−6.11 (4.82)

−5.86 (7.22)

−0.25 (5.06)

−3.65, 3.15

Total coronal hip ROM (°)

MT

9.77 (3.62)

9.29 (2.60)

0.47 (2.19)

−0.86, 1.79

1.12 (−0.72, 3.06)

−0.53

UC

10.04 (4.69)

10.74 (4.79)

−0.70 (2.27)

−2.23, 0.82

Total transverse hip ROM (°)

MT

11.08 (2.65)

11.39 (2.08)

−0.32 (2.49)

−1.83, 1.19

0.46 (−1.45, 2.38)

−0.20

UC

9.12 (5.76)

9.90 (5.02)

−0.78 (1.93)

−2.08, 0.52

  1. MT matched treatment, UC usual care group, ROM range of movement, ES effect size